Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
101.50
+3.63 (3.71%)
At close: Jul 30, 2026, 4:00 PM EDT
101.00
-0.50 (-0.49%)
After-hours: Jul 30, 2026, 7:54 PM EDT
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $8.93 billion as of July 30, 2026. Its market cap has increased by 781.88% in one year.
Market Cap
8.93B
Enterprise Value
8.17B
1-Year Change
781.88%
Ranking
Category
Stock Price
$101.50
ChartMarket Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $8.93B, an increase of 7,890.65%. That is a compound annual growth rate of 52.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 8.93B | 251.14% |
| Dec 31, 2025 | 2.54B | 112.30% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Halozyme Therapeutics | 9.91B |
| Summit Therapeutics | 9.79B |
| Ionis Pharmaceuticals | 9.03B |
| Crinetics Pharmaceuticals | 8.85B |
| Protagonist Therapeutics | 8.73B |
| Kymera Therapeutics | 8.70B |
| Praxis Precision Medicines | 8.23B |
| Immunovant | 8.01B |